Qube Research & Technologies Ltd - MADRIGAL PHARMACEUTICALS INC ownership

MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 259 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2024. The put-call ratio across all filers is 0.47 and the average weighting 0.6%.

Quarter-by-quarter ownership
Qube Research & Technologies Ltd ownership history of MADRIGAL PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2024$309,232
+3949.7%
1,158
+3409.1%
0.00%
Q4 2023$7,636
-99.0%
33
-99.7%
0.00%
-100.0%
Q2 2022$739,000
+19.2%
10,327
+62.3%
0.01%
-28.6%
Q2 2021$620,000
+36.3%
6,364
+63.6%
0.01%0.0%
Q1 2021$455,000
-46.0%
3,891
-45.1%
0.01%
-41.7%
Q3 2020$842,000
+301.0%
7,093
+283.4%
0.01%
+300.0%
Q2 2020$210,0001,8500.00%
Other shareholders
MADRIGAL PHARMACEUTICALS INC shareholders Q2 2024
NameSharesValueWeighting ↓
Paulson & Co. 1,850,000$518,296,00038.31%
Tao Capital Management LP 130,529$36,569,00529.98%
University of Wisconsin Foundation 45,730$12,811,71714.42%
AlpInvest Partners B.V. 84,595$23,700,1358.50%
RTW INVESTMENTS, LP 1,915,862$536,747,8988.31%
Propel Bio Management, LLC 43,032$12,055,8457.82%
Avoro Capital Advisors LLC 2,055,555$575,884,2897.67%
Baker Brothers Advisors 1,974,590$553,201,1347.07%
Tri Locum Partners LP 65,352$18,309,0164.63%
TCG Crossover Management, LLC 149,283$41,823,1254.36%
View complete list of MADRIGAL PHARMACEUTICALS INC shareholders